Psychiatry and Neurology, Neurology · Ann Arbor, MI
NPI
1386693653
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 East Medical Center Dr, 1st Floor Taubman Center Recp C
Ann Arbor, MI, 48109
Phone (734) 936-9010
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
316 services
Medicare patients, 2024
90
Average age 58
Drug cost, 2024
$1.1M
3,013 prescriptions
Company payments, 2025
$1,372
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles E Schultz was code 64615 (musculoskeletal), 97 times for 33 patients. In total Charles E Schultz billed 316 services in 10 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64615 Musculoskeletal | Facility | 97 | 33 | $98.31 | $9,536 |
| 99214 Office E&M - Established | Facility | 78 | 54 | $64.42 | $5,025 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 55 | 46 | $11.42 | $628 |
By year: 2022 $17K for 260 services; 2023 $19K for 271 services; 2024 $20K for 316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles E Schultz prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 315 prescriptions and refills. In total Charles E Schultz wrote 3,013 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 315 | 324 | 43 | $237K |
| Aimovig Autoinjector Erenumab-Aooe | 297 | 327 | 38 | $234K |
| Rizatriptan Rizatriptan Benzoate | 206 | 259 | 42 | $3,960 |
| Sumatriptan Succinate Generic | 150 | 175 | 32 | $9,658 |
| Naratriptan Hcl Generic | 130 | 139 | 28 | $2,981 |
| Nurtec Odt Rimegepant Sulfate | 123 | 124 | 33 | $194K |
| Ondansetron Odt Ondansetron | 118 | 120 | 21 | $1,497 |
| Topiramate Generic | 110 | 293 | 32 | $2,083 |
| Qulipta Atogepant | 104 | 104 | 25 | $112K |
| Nortriptyline Hcl Generic | 86 | 187 | 17 | $1,991 |
| Gabapentin Generic | 82 | 162 | 24 | $2,040 |
| Memantine Hcl Generic | 73 | 124 | 14 | $3,840 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 66 | 66 | 20 | $821 |
| Baclofen Generic | 61 | 84 | 16 | $844 |
| Lamotrigine Generic | 52 | 106 | 15 | $1,598 |
Brand drugs: 1,077 claims; generic drugs: 1,936 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles E Schultz $1,372 ($1,372 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $664.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.